Nutritional modification of inflammatory diseases

Seminars in Veterinary Medicine and Surgery-Small Animal

Volumn 12, Issue 3, 1997, Pages 212-222

  Schoenherr, W D ^a   Jewell, Dennis E ^a,b  

^a Mark Morris Institute   (United States)

^b Hill's Pet Nutrition Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; IMMUNOLOGICAL ADJUVANT; UNSATURATED FATTY ACID;

ANIMAL; ANIMAL DISEASE; ANIMAL FOOD; CAT; CAT DISEASE; DIET THERAPY; DOG; DOG DISEASE; IMMUNOLOGY; INFLAMMATION; NUTRITIONAL STATUS; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ADJUVANTS, IMMUNOLOGIC; ANIMAL NUTRITION PHYSIOLOGY; ANIMALS; CAT DISEASES; CATS; DOG DISEASES; DOGS; FATTY ACIDS; FATTY ACIDS, UNSATURATED; INFLAMMATION; NUTRITIONAL STATUS;

EID: 0031203721     PISSN: 08820511     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1096-2867(97)80035-7     Document Type: Article

References (72)

1. Singer SJ, Nicholson GL: The fluid mosaic model of the structure of cell membranes. Science 175:720-731, 1972
2. Adams DA, Freauff SJ, Erickson KL: Biophysical characterization of dietary lipid influences on lymphocytes, in Kabana J (ed): Pharmacological Role of Lipids, vol 2. Champaign, IL, American Oil Chemists Society, 1985
3. Johnson M, Carey F, McMillan RM: Alternative pathways of arachidonate metabolism: Prostaglandins, thromboxane and leukotrienes, in Campbell PN, Marshall RD (eds): Essays in Biochemistry. New York, NY, Academic Press, 1983, pp 40-141
4. Sigal E: The molecular biology of mammalian arachidonic acid metabolism. Am J Physiol 260:L13-L28, 1991
5. Sumida C, Graber R, Nunez E: Role of fatty acids in signal transduction: Modulators and messengers. Prostaglandins, Leukotrienes and Essential Fatty Acids 48:117-122, 1993
6. Lands WEM: N-3 fatty acids as precursors for active metabolic substances: Dissonance between expected and observed events. J Exp Med 225:1-20, 1989
7. Lokesh BR, German JB, Kinsella JE: Differential effect of docosahexaenoic acid and eicosapentaenoic acid on suppression of lipoxygenase pathway in peritoneal macrophages. Biochimica et Biophysica Acta 958:99-107, 1988
8. Lokesh BR, Kinsella JE: Modulation of prostaglandin synthesis in mouse peritoneal macrophages by enrichment of lipids with either eicosapentaenoic or docosahexaenoic acids in vitro. Immunobiology 175:406-419, 1987
9. Broughton KS, Whelan J, Hardardottir I, et al: Effect of increasing the dietary (n-3) to (n-6) polyunsaturated fatty acid ratio on murine liver and peritoneal cell fatty acids and eicosanoid formation. J Nutr 121:155-164, 1991
10. Croft LD, Beilin LJ, Legge FM, et al: Effects of diet enriched in eicosapentaenoic or docosapentaenoic acids on prostanoid metabolism in the rat. Lipids 22:647-650, 1987
11. Horrobin DF, Manku MS: Clinical biochemistry of essential fatty acids, in Horrobin DF (ed): Omega-6 Essential Fatty Acids: Pathophysiology and Roles in Clinical Medicine. New York, NY, Alan R Liss, 1990, pp 21-53
12. Manku MS, Morse-Fisher N, Horrobin DF: Changes in human plasma essential fatty acid levels as a result of administration of linoleic acid and gamma-linoleic acid. Eur J Clin Nutr 42:55-60, 1988
13. Meydani SN, Endres S, Woods MM, et al: Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: Comparison between young and older women. J Nutr 121:547-555, 1991
14. Hwang D: Essential fatty acids and the immune response. FASEB J 3:2052-2061, 1989
15. Magrum IJ, Johnston PV: Modulation of prostaglandin synthesis in rat peritoneal macrophages with omega-3 fatty acids. Lipids 18:514-521, 1983
16. Lokesh BR, Black JM, German JB, et al: Docosahexaenoic acid and other dietary omega-3 polyunsaturated fatty acids suppress leukotriene synthesis by mouse peritoneal macrophages. Lipids 23:968-972, 1988
17. Stossel TP, Mason RJ, Smith AL: Lipid peroxidation by human blood phagocytos. J Clin Invest 54:638-645, 1974
18. Goodwin JS, Ceuppens J: Regulation of the immune response by prostaglandins. J Clin Immunol 3:295-315, 1983
19. Calder PC: Effects of fatty acids and dietary lipids on cells of the immune system. Proceedings of the Nutrition Society 55:127-150, 1996
20. Calder PC, Bond JA, Harvey DJ, et al: Uptake of saturated and unsaturated fatty acids into macrophage lipids and their effect upon macrophage adhesion and phagocytosis. Biochem J 269:807-814, 1990
21. Endres S, Ghorbani R, Kelley EV, et al: The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 320:265-271, 1989
22. Endres S, Meydani SN, Ghorbani R, et al: Dietary supplementation with n-3 fatty acids suppresses interleukin-2 production and mononuclear cell proliferation. J Leuk Biol 54:599-603, 1993
23. Baldie G, Kaimakamis D, Rotondo D: Fatty acid modulation of cytokine release from human monocytic cells. Biochimica et Biophysica Acta 1179:125-133, 1993
24. Lee TH, Hoover RL, Williams JD, et al: Dietary enrichment with eicosapentaenoic and docosahexaenoic acids in human subjects impairs in vitro neutrophil and monocyte function function and leukotriene generation. N Engl J Med 312:1217-1224, 1985
25. Watson J, Madhok R, Wijelath E, et al: Mechanism of action of polyunsaturated fatty acids in rheumatoid arthritis. Biochemical Society Transactions 18:284-285, 1990
26. Bennett D, May C: Joint diseases of dogs and cats, in Ettinger SJ, Feldman EC (eds): Textbook of Veterinary Internal Medicine. Philadelphia, PA, Saunders, 1995, pp 2032-2077
27. Ball J, Sharp J: Osteoarthritis, in Scott JT (ed): Copeman's Textbook of the Rheumatic Diseases. Edinburgh, UK, Churchill Livingstone, 1978, chapter 25
28. Rose RJ: The intra-articular use of sodium hyaluronate for the treatment of osteoarthritis in the horse. N Z Vet J 27:5-8, 1979
29. Kunkel SL, Ogawa H, Ward PA, et al: Suppression of chronic inflammation by evening primrose oil. Progress in Lipid Research 20:885-888, 1981
30. 1 precursors cis-linoleic acid and gamma-linoleic acid. Scand J Rheumatol 12:85-88, 1983
31. Janlli J, Isomaki H, Laitinen O, et al: Linoleic acid treatment in inflammatory arthritis. Int J Clin Pharmacol Ther Toxicol 23:89-91, 1983
32. Prickett JD, Trentham DE, Robinson DR. Dietary fish oil augments the induction of arthritis in rats immunized with Type II collagen. J Immunol 132:725-729, 1984
33. Leslie CA, Gonnerman WA, Ullman MD, et al: Dietary fish oil modulated macrophage fatty acid and decreases arthritis susceptibility in mice. J Exp Med 162:1336-1349, 1985
34. Kremer JM, Michalek AV, Lininger L, et al: Effects of manipulation of dietary fatty acids on clinical manifestations of rheumatoid arthritis. Lancet 1:184-187, 1985
35. Kremer JM, Jubiz W, Michalek A, et al: Fish-oil fatty acid supplementation in active rheumatoid arthritis. Ann Intern Med 106:497-503, 1987.
36. Sperling RI, Weinblatt M, Robin JL, et al: Effects of dietary supplementation with marine fish oil on leukocyte lipid mediator generation and function in rheumatoid arthritis. Arthritis Rheum 30:988-997, 1987
37. Belch JJF, Ansell D, Madhok R, et al: Effects of altering dietary essential fatty acids on requirements for non-steroidal anti-inflammatory drugs in patients with rheumatoid arthritis: a double blind placebo controlled study. Ann Rheum Dis 47:96-104, 1988
38. Cleland LG, French JK, Betts WH, et al: Clinical and biochemical effects of dietary fish oil supplements in rheumatoid arthritis. J Rheumatol 15:1471-1475, 1988
39. Jantti J, Nikkari T, Solakivi T, et al: Evening primrose oil in rheumatoid arthritis: Changes in serum lipids and fatty acids. Ann Rheum Dis 48:124-127, 1989
40. Kremer JM, Lawrence DA, Jubisz W, et al: Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis; Clinical and immunological effects. Arthritis Rheum 33:810-820, 1990
41. Van der Tempel H, Tulleken JE, Limbuerg JE, et al: Effects of fish oil supplementation in rheumatoid arthritis. Ann Rheum Dis 49:76-80, 1990
42. Kjeldsen-Kragh J, Lund JA, Ruse T, et al: Dietary omege-3 fatty acid supplementation and naproxen treatment in patients with rheumatoid arthritis. J Rheumatol 19:1531-1536, 1992
43. Miller WH, Scott DW, Wellington JR: Treatment of dogs with hip arthritis with a fatty acid supplement. Canine Practice 17:6-8, 1992
44. Nielsen GL, Faarvang KL, Thomsen BS, et al: The effects of dietary supplementation with n-3 polyunsaturated fatty acids in patients with rheumatoid arthritis: A randomized, double blind trial. Eur J Clin Invest 22:687-691, 1992
45. Skoldstam L, Borjesson O, Kjallman A, et al: Effect of six months of fish oil supplementation in stable rheumatoid arthritis. A double blind, controlled study. Scand J Rheumatol 21:178-185, 1992
46. Lau CS, Morley KD, Belch JJF: Effects of fish oil supplementation on non-steroidal anti-inflammatory drug requirement in patients with mild rheumatoid arthritis-a double blind placebo controlled study. Br J Rheumatol 32:982-989, 1993
47. Geusens P, Wouters C, Nijs J, et al: Long-term effects of omega-3 fatty acid supplementation in active rheumatoid arthritis - a 12-month double blind, controlled study. Arthritis Rheum 37:824-829, 1994
48. Kremer JM, Lawrence DA, Petrillo GF, et al: Effects of high-dose fish oil on rheumatoid arthritis after stopping nonsteroidal anti-inflammatory drugs. Clinical and immune correlates. Arthritis Rheum 38:1107-1114, 1995
49. Campbell KL: Fatty acid supplementation and skin disease. Vet Clin North Am 20:1475-1486, 1990
50. White PD: Essential fatty acids: Use in management of canine atopy. Compendium of Continuing Education for Practicing Veterinarians 15:451-457, 1993
51. Manku MS, Horrobin DF, Morse NL: Reduced levels of prostaglandin precursors in the blood of atopic patients: Defective delta-6-desaturase function as a biochemical basis for atopy. Prostaglandins 9:615-628, 1982
52. Manku MS, Horrobin DF, Morse NL: Essential fatty acids in the plasma phospholipids of patients with atopic eczema. Br J Dermatol 110:643-648, 1984
53. Scott DW, Buerger RG: Nonsteroidal anti-inflammatory agents in the management of canine pruritus. J Am Anim Hosp Assoc 24:425-428, 1988
54. Miller WH, Scott DW, Wellington JR: Efficacy of DVM derm caps liquid in the management of allergic and inflammatory dermatoses of the cat. J Am Anim Hosp Assoc 29:37-40, 1993
55. Scott DW, Buerger RG: Nonsteroidal anti-inflammatory agents in the management of canine pruritus. J Am Anim Hosp Assoc 24:425-428, 1988
56. Miller WH, Griffin CE, Scott DW, et al: Clinical trial of DVM DermCaps in the treatment of allergic skin disease in dogs: A nonblinded study. J Am Anim Hosp Assoc 25:163-168, 1989
57. Lloyd DH, Thomsett LR: Essential fatty acid supplementation in the treatment of canine atopy: A preliminary study. Vet Dermatol 1:41-44, 1989
58. Lloyd DH: Essential fatty acids and skin disease. J Small Anim Pract 30:207-212, 1989
59. Scott DW, Miller DH: Nonsteroidal management of canine pruritus: Chlorpheniramine and fatty acid supplement (DVM DermCaps) in combination, and the fatty acid supplement at twice the manufacturers recommended dosage. Cornell Veterinarian 80:381-387, 1990
60. Scarff D, Harvey R, McEwan N: A multicentre placebo-controlled practitioner study to investigate the effect of evening primrose oil in canine atopic dermatosis (abstr), in VonTschnamer C, Halliwell REW (eds): Advances in Veterinary Dermatology, vol 1. Philadelphia, PA, BailliereTindall, 1990, p 481
61. Paradis M, Lemay S, Scott DW: The efficacy of clemastine (Tavist), a fatty acid-containing product (DVM DermCaps) and the combination of both in the management of canine pruritus. Vet Dermatol 2:17-20, 1991
62. Scott DW, Miller WH, Decker GA, et al: Comparison of the clinical efficacy of two commercial fatty acid supplements (EfaVet & DVM DermCaps), evening primrose oil and cold water marine fish oil in the management of allergic pruritus in dogs: A double blinded study. Cornell Veterinarian 82:319-329, 1992
63. Miller WH, Scott DW, Wellington JR: Investigation on the antipruritic effects of ascorbic acid given alone or in combination with a fatty acid supplement to dogs with allergic skin disease. Canine Practice 17:11-13, 1992
64. Scarff DH, Lloyd DH: Double blind, placebo-controlled, crossover study of evening primrose oil in the treatment of canine atopy. Vet Rec 131:97-99, 1992
65. Bond R, DH Lloyd: A double-blind comparison of olive oil and a combination of evening primrose oil and fish oil in the management of canine atopy. Vet Rec 131:558-560, 1992
66. White PD: Effects of gamma linolenic acid supplementation on serum and cutaneous fatty acid profiles and cutaneous eicosanoids in normal and atopic dogs. A double-blind, placebo-controlled, crossover study (abstr), in Proceedings, Second world congress of veterinary dermatology, Montreal, Canada, 1992, pp 32-33
67. Logas D, Kunkle GA: Double-blinded crossover study with marine oil supplementation containing high-dose eicosapentaenoic acid for the treatment of canine pruritic skin disease. Vet Dermatol 5:99-104, 1994
68. Reinhart GA, Scott DW, Miller WH: A controlled dietary omega-6:omega-3 ratio reduces pruritis in non-food allergic atopic dogs, in Carey DP, Norton SA, Boiser SM (eds): Recent Advances in Canine and Feline Nutrition Research: Proceedings of the 1996 lams International Nutrition Symposium. Wilmington, OH, Orange Frazer Press, 1996, pp 277-284
69. Harvey RG: Management of feline miliary dermatitis by supplementing the diet with essential fatty acids. Vet Rec 128:326-329, 1991
70. Harvey RG: A comparison of evening primrose oil and sunflower oil for the management of papulocrustous dermatitis in cats. Vet Rec 133:571-573, 1993
71. Harvey RG: Effect of varying proportions of evening primrose oil and fish oil on cats with crusting dermatosis (miliary dermatitis). Vet Rec 133:208-211, 1993
72. Miller WH, Scott DW, Wellington JR: Efficacy of DVM Derm Caps Liquid in the management of allergic and inflammatory dermatoses of the cat. J Am Anim Hosp Assoc 29:37-40, 1993